We are live on ! Find out more
ERNA icon

Ernexa Therapeutics

7 hedge funds and large institutions have $7.63M invested in Ernexa Therapeutics in 2015 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

1,864% more capital inflows, than outflows

Capital inflows: $354K | Capital outflows: $18K

21.12% more ownership

Funds ownership: 0% → 21.12% (+21%)

0% more funds holding

Funds holding: 7 → 7 (0)

Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AIC
AWM Investment Company
New York
+$354K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$18K

ERNA Hedge Fund Activity: Q1 2015 in Review

7 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in Ernexa Therapeutics (ERNA) for Q1 2015, worth a combined $7.63M — down 3.7% from $7.92M a quarter earlier.

Fund positioning in ERNA was balanced in Q1 2015: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was AWM Investment Company, adding an estimated $354K. The largest seller was Citadel Advisors, cutting an estimated $18K.

  • 7 institutional investors held Ernexa Therapeutics (ERNA) as of Q1 2015, unchanged from Q4 2014.
  • Funds reported $7.63M of Ernexa Therapeutics stock for Q1 2015, down 3.7% quarter-over-quarter.
  • 0 funds opened new Ernexa Therapeutics positions in Q1 2015 and 0 closed out.
  • The largest Ernexa Therapeutics buyer in Q1 2015 was AWM Investment Company, an estimated $354K added.
  • The largest Ernexa Therapeutics seller in Q1 2015 was Citadel Advisors, an estimated $18K sold.

Based on aggregated 13F filings for Q1 2015.